InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Amylyx Pharmaceuticals, Inc.

AMLX Clue Score40
United States Fiscal year ends December CIK 0001658551 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

By person

8 insiders · 35 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Joshua B Cohen
Co-Chief Executive Officer
—
$3.60M (7) scheduled
−$3.60M
3,613,123
3.24%
$100.07M
+12.2%
Justin B. Klee
Co-Chief Executive Officer
—
$3.59M (7) scheduled
−$3.59M
3,613,056
3.24%
$100.07M
+13.5%
Gina Mazzariello
Chief Legal Officer
—
$1.05M (7) scheduled
−$1.05M
190,838
0.1713%
$5.29M
+33.7%
George M Milne Jr
Director
—
$830.90K (1) scheduled
−$830.90K
782,881
0.7026%
$21.68M
−8.8%
James M Frates
Chief Financial Officer
—
$553.72K (5)
−$553.72K
273,625
0.2456%
$7.58M
+105.0%
Camille L Bedrosian
Chief Medical Officer
—
$513.49K (4)
−$513.49K
278,064
0.2496%
$7.70M
+93.4%
Karen Firestone
Director
$152.18K (2)
—
+$152.18K
116,900
0.1049%
$3.24M
+112.5%
Bernhardt G Zeiher
Director
—
—
—
10,000
0.0090%
$276.97K
—